Methods for treating rheumatoid arthritis using a CTLA-4 fusion protein
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 25, 2010
Grant Date -
May 10, 2007
app pub date -
Nov 3, 2006
filing date -
Nov 4, 2005
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to methods for delivery of fusion polypeptides into cells. Methods are provided for local delivery of fusion polypeptides, e.g., through the skin, eye and the airway, to prevent allergic inflammation, airway hyper-responsiveness and to block T cell activation. Methods for delivery of fusion polypeptides to suppress graft rejection are also provided.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully